Adrenal Insufficiency Calculator- Free Cortisol Interpreter and Glucocorticoid Dose Conversion Tool

Adrenal Insufficiency Calculator – Free Cortisol Interpreter and Glucocorticoid Dose Conversion Tool | Super-Calculator.com

JavaScript Required

This adrenal insufficiency calculator requires JavaScript to interpret cortisol levels, convert glucocorticoid doses, calculate stress dosing, and estimate hydrocortisone replacement doses. Please enable JavaScript in your browser to use this free cortisol assessment and steroid conversion tool.

Adrenal Insufficiency Calculator

Interpret morning cortisol and ACTH levels for adrenal insufficiency diagnosis, convert glucocorticoid doses between hydrocortisone, prednisolone, dexamethasone, and other steroids, calculate sick day stress doses based on illness severity, and estimate physiologic replacement doses using body surface area and weight.

Important Medical Disclaimer

This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.

Cortisol Level Interpreter

Morning Serum Cortisol10.0 mcg/dL

Cortisol Measurement Unit

Plasma ACTH Level50 pg/mL

Where Your Morning Cortisol Falls on the Diagnostic Reference Range

10.0

0310152030+

Indeterminate – Dynamic Testing Recommended

Cortisol (nmol/L)276

ACTH InterpretationElevated

Likely AI TypeEvaluate Further

Glucocorticoid Dose Converter

Current Steroid Medication

Current Dose (mg)20

Hydrocortisone Equivalent Dose

20.0 mg

Cortisone Acetate

25.0 mg

Prednisolone

5.0 mg

Prednisone

5.0 mg

Methylprednisolone

4.0 mg

Triamcinolone

4.0 mg

Dexamethasone

0.75 mg

Stress Dose Calculator

Your Daily Hydrocortisone Dose (mg)20

Select Physiologic Stress Severity Level:

Mild Stress

Low fever, mild viral illness

40 mg/day

Moderate Stress

Fever above 38C, minor procedure

60 mg/day

Severe Stress

Major surgery, sepsis, trauma

200 mg/day

Stress Dose on the Hydrocortisone Dosing Range (mg/day)

40 mg

154060100200

Mild Stress Dosing Protocol: Double your daily hydrocortisone dose. Take 20 mg twice daily (or equivalent split). Continue for 2-3 days or until symptoms resolve. Contact your healthcare provider if needed beyond 3 days.

Replacement Dose Estimator

Body Weight70 kg

Height170 cm

Calculated Body Surface Area (Du Bois Formula)

1.81 m2

BSA-Based Low (8 mg/m2/day)

14.5 mg

BSA-Based High (10 mg/m2/day)

18.1 mg

Weight-Based Low (0.12 mg/kg)

8.4 mg

Weight-Based High (0.15 mg/kg)

10.5 mg

Your Estimated Replacement Range on the Recommended Hydrocortisone Dose Spectrum

14.5-18.1 mg

10152025

Important Medical Disclaimer

About This Adrenal Insufficiency Calculator

This adrenal insufficiency calculator is designed for healthcare professionals, patients with Addison disease or secondary adrenal insufficiency, and medical students seeking to interpret cortisol laboratory values, convert between glucocorticoid medications, determine appropriate stress doses during illness, and estimate physiologic hydrocortisone replacement doses. The four integrated modules address the most common clinical calculations needed in adrenal insufficiency management.

The cortisol interpreter module uses diagnostic thresholds from the Endocrine Society 2016 Clinical Practice Guideline and recent literature on assay-specific cortisol cutoffs. The glucocorticoid converter applies standard potency ratios established through pharmacokinetic studies for hydrocortisone, cortisone acetate, prednisolone, prednisone, methylprednisolone, triamcinolone, and dexamethasone. The stress dose module implements consensus sick day rules from the Endocrine Society, Society for Endocrinology, and the NICE 2024 guideline on adrenal insufficiency management.

The dashboard-style layout presents all four modules simultaneously with gradient zone bar visualizations that help users see at a glance where their cortisol level, stress dose, or replacement dose falls relative to clinical reference ranges. The replacement dose estimator uses the Du Bois body surface area formula to calculate individualized hydrocortisone dose ranges based on the physiologic cortisol production rate of 5 to 10 mg per square meter per day.

Adrenal Insufficiency Calculator: Complete Guide to Cortisol Assessment, Glucocorticoid Conversion, and Stress Dosing

Adrenal insufficiency is a potentially life-threatening endocrine disorder characterized by inadequate production of cortisol by the adrenal glands. Whether caused by primary adrenal failure (Addison disease), pituitary dysfunction (secondary adrenal insufficiency), or hypothalamic problems (tertiary adrenal insufficiency), this condition demands precise diagnostic evaluation and careful management of glucocorticoid replacement therapy. The Adrenal Insufficiency Calculator above provides healthcare professionals and patients with essential tools for interpreting cortisol laboratory values, converting between different glucocorticoid medications, estimating physiologic replacement doses, and calculating appropriate stress doses during illness or surgery.

Understanding adrenal insufficiency requires familiarity with the hypothalamic-pituitary-adrenal (HPA) axis, the biochemical markers used for diagnosis, and the pharmacologic principles governing glucocorticoid replacement therapy. This guide covers the clinical context behind each calculator module, explains the formulas and reference ranges used, and provides actionable guidance for managing this complex condition safely.

Understanding the Hypothalamic-Pituitary-Adrenal Axis

The hypothalamic-pituitary-adrenal axis is a sophisticated hormonal feedback system that regulates cortisol production. The hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH then acts on the adrenal cortex to stimulate the synthesis and secretion of cortisol, the body’s primary glucocorticoid hormone. Cortisol, in turn, exerts negative feedback on both the hypothalamus and pituitary to maintain homeostasis.

Cortisol follows a distinct circadian rhythm, with peak levels occurring in the early morning hours (typically between 6:00 AM and 8:00 AM) and the lowest levels around midnight. This diurnal variation is critically important for diagnostic testing, as morning cortisol measurements provide the most clinically meaningful baseline assessment. The normal morning serum cortisol level typically ranges from 6 to 20 mcg/dL (165 to 552 nmol/L), although exact reference ranges vary by assay.

Daily cortisol production in healthy adults is approximately 5 to 10 mg per square meter of body surface area per day, equivalent to roughly 15 to 25 mg of hydrocortisone. During physiologic stress such as illness, surgery, or trauma, cortisol production can increase dramatically, sometimes reaching 200 to 300 mg per day in severe stress states. This stress response is essential for maintaining blood pressure, blood glucose levels, and immune function during critical illness.

Types of Adrenal Insufficiency and Their Distinguishing Features

Primary adrenal insufficiency (Addison disease) results from destruction or dysfunction of the adrenal cortex itself, leading to deficiency of all adrenal cortical hormones: glucocorticoids, mineralocorticoids, and adrenal androgens. The most common cause worldwide is autoimmune adrenalitis, accounting for approximately 80 to 90 percent of cases in developed countries. Other causes include infections (particularly tuberculosis in developing regions), bilateral adrenal hemorrhage, infiltrative diseases, and medications that inhibit adrenal steroidogenesis. Primary adrenal insufficiency has a prevalence of approximately 100 to 140 cases per million inhabitants and an incidence of about 4 cases per million per year.

Secondary adrenal insufficiency results from insufficient ACTH production by the pituitary gland, most commonly due to pituitary tumors, pituitary surgery, or radiation therapy. Because ACTH is required for cortisol and adrenal androgen synthesis but not for aldosterone production (which is regulated primarily by the renin-angiotensin-aldosterone system), patients with secondary adrenal insufficiency typically do not have mineralocorticoid deficiency. Secondary adrenal insufficiency is considerably more common than primary, with an estimated prevalence of 150 to 280 per million inhabitants.

Tertiary adrenal insufficiency, the most common form overall, results from suppression of the HPA axis by chronic exogenous glucocorticoid administration. Patients who have received supraphysiologic doses of glucocorticoids for more than two to three weeks are at risk of HPA axis suppression, and abrupt discontinuation can precipitate adrenal crisis. The degree and duration of suppression depend on the dose, potency, duration, and route of glucocorticoid administration.

Key Point: Distinguishing Primary from Secondary Adrenal Insufficiency

In primary adrenal insufficiency, ACTH levels are elevated (the pituitary attempts to stimulate the failing adrenal glands), while in secondary adrenal insufficiency, ACTH levels are low or inappropriately normal. Additionally, primary adrenal insufficiency affects mineralocorticoid production, requiring fludrocortisone replacement, whereas secondary adrenal insufficiency typically does not.

Diagnostic Assessment of Adrenal Insufficiency

The diagnosis of adrenal insufficiency begins with clinical suspicion based on characteristic symptoms: fatigue, weakness, weight loss, anorexia, nausea, hypotension, and, in primary adrenal insufficiency, hyperpigmentation. Laboratory evaluation proceeds through a systematic approach beginning with baseline hormone measurements and, when indicated, dynamic stimulation testing.

The initial diagnostic step involves measuring an early morning (8:00 AM) serum cortisol level. A morning cortisol below 3 mcg/dL (83 nmol/L) is highly suggestive of adrenal insufficiency, while a level above 15 mcg/dL (414 nmol/L) with most modern immunoassays effectively excludes the diagnosis. Values between 3 and 15 mcg/dL represent an indeterminate zone requiring further evaluation with dynamic testing. Some contemporary references suggest that a morning cortisol above 14 mcg/dL or a dehydroepiandrosterone sulfate (DHEAS) level above 65 mcg/dL can rule out adrenal insufficiency without the need for stimulation testing.

Concurrent measurement of plasma ACTH is essential for differentiating primary from secondary adrenal insufficiency. In primary adrenal insufficiency, ACTH is typically elevated above 2 times the upper limit of normal (often greater than 100 pg/mL or 22 pmol/L), while in secondary or tertiary adrenal insufficiency, ACTH is low or inappropriately normal relative to the low cortisol level.

Morning Cortisol Interpretation Framework

Cortisol less than 3 mcg/dL = AI Very Likely | 3 to 10 mcg/dL = Indeterminate (Dynamic Test Needed) | 10 to 15 mcg/dL = AI Less Likely | Greater than 15 mcg/dL = AI Excluded

Morning cortisol measured at 8:00 AM. Thresholds are assay-dependent and should be interpreted with the specific laboratory reference ranges. Newer monoclonal immunoassays may have lower cutoffs (14 mcg/dL rather than 18 mcg/dL). To convert mcg/dL to nmol/L, multiply by 27.6.

The ACTH Stimulation Test (Cosyntropin Test)

The standard-dose ACTH stimulation test, also called the cosyntropin stimulation test or short Synacthen test, is considered the gold standard for confirming adrenal insufficiency. The test involves administering 250 mcg of synthetic ACTH (cosyntropin) intravenously and measuring serum cortisol at baseline and at 30 and 60 minutes post-injection. A peak cortisol response of 18 mcg/dL (500 nmol/L) or greater at either time point has traditionally been used to exclude adrenal insufficiency.

However, it is important to note that this 18 mcg/dL threshold was established using older polyclonal antibody cortisol assays. With the widespread adoption of newer, more specific monoclonal antibody immunoassays and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods, many experts now recommend a lower cutoff of 14 to 15 mcg/dL (386 to 414 nmol/L) for the stimulated cortisol response. Clinicians should be aware of which assay their laboratory uses and apply the appropriate diagnostic threshold.

The insulin tolerance test (ITT) is considered the definitive test for assessing the entire HPA axis, particularly useful when secondary adrenal insufficiency is suspected. This test involves administering intravenous insulin to induce hypoglycemia (blood glucose below 2.2 mmol/L or 40 mg/dL), which triggers a stress response and cortisol release. However, the ITT is contraindicated in patients with cardiovascular disease, epilepsy, and elderly individuals, limiting its practical utility. A peak cortisol response of 18 mcg/dL or greater (or the assay-specific equivalent) during adequate hypoglycemia excludes adrenal insufficiency.

ACTH Stimulation Test Interpretation

Stimulated Cortisol at 30 or 60 min: Less than 14 mcg/dL (older assay: less than 18 mcg/dL) = Adrenal Insufficiency Confirmed

The standard dose is 250 mcg cosyntropin IV. A peak cortisol above the assay-specific cutoff at either 30 or 60 minutes excludes adrenal insufficiency. The low-dose (1 mcg) test is an alternative when cosyntropin supply is limited. Always interpret results in the context of clinical presentation and the specific cortisol assay used by your laboratory.

Glucocorticoid Replacement Therapy

The cornerstone of adrenal insufficiency treatment is glucocorticoid replacement therapy, most commonly with hydrocortisone (cortisol). The Endocrine Society Clinical Practice Guideline recommends hydrocortisone at a dose of 15 to 25 mg per day, divided into two or three doses, with the largest dose given upon awakening to mimic the natural cortisol circadian rhythm. A typical regimen might be 10 mg on waking, 5 mg at midday, and 5 mg in the late afternoon, although individual requirements vary considerably.

Alternative glucocorticoids include cortisone acetate (20 to 35 mg per day), which is converted to cortisol in the liver, and prednisolone (3 to 5 mg per day), which has a longer duration of action and may be taken once or twice daily. Prednisolone may be particularly useful in patients with compliance difficulties. Dexamethasone is generally not recommended for replacement therapy due to its very long duration of action, high potency, and difficulty in dose titration, which increases the risk of Cushingoid side effects.

Monitoring of glucocorticoid replacement adequacy relies primarily on clinical assessment rather than laboratory measurements. Signs of under-replacement include fatigue, nausea, weight loss, hypotension, and hypoglycemia, while signs of over-replacement include weight gain, moon facies, striae, easy bruising, hypertension, and hyperglycemia. Cortisol day curves (measuring serum cortisol at multiple time points throughout the day) have been studied but are of limited clinical value for routine monitoring.

Key Point: Individualized Dosing Is Essential

The daily cortisol production rate varies approximately 5-fold between individuals. Starting with 20 mg of hydrocortisone per day and titrating based on clinical response allows for personalization. Some patients may require as little as 10 to 15 mg per day, while others need the full 25 mg. The goal is the lowest dose that maintains well-being while avoiding glucocorticoid excess.

Glucocorticoid Equivalency and Conversion

Understanding glucocorticoid equivalencies is essential when switching between different steroid medications or when patients present on various glucocorticoid regimens. The relative potencies of commonly used glucocorticoids, based on their anti-inflammatory (glucocorticoid) effects, are well established through pharmacokinetic studies and clinical experience.

The standard equivalency table uses hydrocortisone 20 mg as the reference point. Equivalent doses are: cortisone acetate 25 mg, prednisolone 5 mg, prednisone 5 mg, methylprednisolone 4 mg, triamcinolone 4 mg, dexamethasone 0.75 mg, and betamethasone 0.6 mg. These equivalencies are based on glucocorticoid (anti-inflammatory) potency and do not account for differences in mineralocorticoid activity, duration of action, or biologic half-life.

Mineralocorticoid activity is an important consideration, particularly in primary adrenal insufficiency. Hydrocortisone and cortisone acetate have meaningful mineralocorticoid activity (approximately equivalent to 0.05 mg of fludrocortisone per 20 mg of hydrocortisone), while prednisolone and prednisone have minimal mineralocorticoid effect, and dexamethasone and methylprednisolone have essentially none. When converting from hydrocortisone to a steroid with less mineralocorticoid activity, additional fludrocortisone may be required in patients with primary adrenal insufficiency.

Glucocorticoid Equivalency Formula

Equivalent Dose = (Current Dose / Current Drug Factor) x Target Drug Factor

Conversion factors relative to hydrocortisone 1: Hydrocortisone = 1, Cortisone Acetate = 0.8, Prednisolone = 4, Prednisone = 4, Methylprednisolone = 5, Triamcinolone = 5, Dexamethasone = 26.67, Betamethasone = 33.33. For example, 20 mg hydrocortisone = 5 mg prednisolone = 0.75 mg dexamethasone.

Stress Dosing and Sick Day Rules

One of the most critical aspects of adrenal insufficiency management is the appropriate adjustment of glucocorticoid doses during physiologic stress. Unlike healthy individuals whose adrenal glands can dramatically increase cortisol output in response to illness, trauma, or surgery, patients with adrenal insufficiency must manually increase their glucocorticoid intake to prevent adrenal crisis, a potentially fatal medical emergency.

Stress dosing guidelines vary somewhat between international organizations but generally follow a graduated approach based on the severity of the stress. For minor stress such as mild viral illness with temperature below 38 degrees Celsius (100.4 degrees Fahrenheit), the usual recommendation is to double the daily oral hydrocortisone dose and continue this for the duration of the illness, typically 2 to 3 days. For moderate stress such as febrile illness with temperature above 38 degrees Celsius, dental procedures, or minor outpatient surgery under local anesthesia, the recommendation is generally to double or triple the daily dose.

For major physiologic stress such as major surgery, severe trauma, critical illness, or sepsis, patients require parenteral hydrocortisone at stress doses. The current recommendation from multiple guidelines is 200 mg of hydrocortisone per 24 hours, given either as a continuous intravenous infusion or as 50 mg intravenously or intramuscularly every 6 hours. This should continue until the patient is clinically stable and able to resume oral medication, at which point the dose can be gradually tapered back to maintenance levels.

For patients unable to take oral medication due to vomiting or diarrhea, intramuscular hydrocortisone injection is essential. Patients with known adrenal insufficiency should carry an emergency injection kit containing hydrocortisone 100 mg for self-administration or administration by a caregiver. If vomiting occurs within 30 minutes of an oral dose, the dose should be repeated once vomiting subsides, doubled from the original amount. If vomiting recurs, intramuscular hydrocortisone should be administered and the patient should seek emergency medical attention.

Key Point: Stress Dosing Is Time-Critical

Failure to increase glucocorticoid doses during illness is the leading preventable cause of adrenal crisis. Studies show that even educated patients frequently fail to correctly implement sick day rules. The rate of adrenal crises remains approximately 6.3 per 100 patient-years, with gastrointestinal infections and fever being the most common triggers.

Adrenal Crisis: Recognition and Emergency Management

Adrenal crisis is an acute, life-threatening medical emergency characterized by severe hypotension, dehydration, electrolyte abnormalities (hyponatremia, hyperkalemia in primary adrenal insufficiency), and altered consciousness. It can occur in patients with known adrenal insufficiency who fail to increase their glucocorticoid dose during illness, who cannot absorb oral medication due to vomiting or diarrhea, or who abruptly discontinue glucocorticoid therapy. Adrenal crisis can also be the first presentation of previously undiagnosed adrenal insufficiency.

Emergency management involves immediate administration of intravenous hydrocortisone 100 mg as a bolus, followed by 200 mg per 24 hours (50 mg every 6 hours or continuous infusion). Simultaneous aggressive fluid resuscitation with intravenous normal saline is essential. At high doses (above 50 mg every 6 hours), hydrocortisone provides sufficient mineralocorticoid activity that separate fludrocortisone administration is not needed until the dose is reduced to maintenance levels. Dextrose-containing fluids should be considered if hypoglycemia is present.

All patients with adrenal insufficiency should wear medical alert identification and carry an emergency steroid card detailing their condition, medications, and instructions for emergency glucocorticoid administration. In many countries, standardized steroid emergency cards have been developed to facilitate rapid recognition and treatment by emergency medical personnel who may be unfamiliar with the condition.

Body Surface Area and Weight-Based Dosing

Physiologic cortisol production is most accurately estimated relative to body surface area (BSA) rather than body weight alone. The normal daily cortisol production rate is approximately 5 to 10 mg per square meter of BSA per day, with most estimates centering around 5.7 to 7.4 mg per square meter per day. This corresponds to approximately 15 to 25 mg of oral hydrocortisone when accounting for bioavailability.

Body surface area can be estimated using the Du Bois formula, which uses both height and weight: BSA (in square meters) = 0.007184 multiplied by weight (in kilograms) raised to the power of 0.425, multiplied by height (in centimeters) raised to the power of 0.725. For clinical practice, many providers use simplified weight-based dosing of approximately 8 to 10 mg per square meter per day of hydrocortisone, recognizing that individual requirements vary considerably based on absorption, metabolism, and clinical response.

Body Surface Area (Du Bois Formula)

BSA (m2) = 0.007184 x Weight(kg)^0.425 x Height(cm)^0.725

Used to estimate physiologic hydrocortisone replacement dose. Typical replacement: 8 to 10 mg/m2/day hydrocortisone for adults. Sick day dosing for children targets approximately 30 mg/m2/day divided into four equal doses. For adults, the maximum recommended stress dose is 200 mg hydrocortisone per 24 hours for critical illness.

Mineralocorticoid Replacement in Primary Adrenal Insufficiency

Patients with primary adrenal insufficiency require mineralocorticoid replacement in addition to glucocorticoids, as the destruction of the adrenal cortex also impairs aldosterone production. Fludrocortisone is the standard mineralocorticoid replacement, typically started at 50 to 100 mcg daily and titrated to a range of 50 to 300 mcg daily based on clinical assessment. Patients with secondary or tertiary adrenal insufficiency generally do not require mineralocorticoid replacement because aldosterone secretion, regulated primarily by the renin-angiotensin system, remains intact.

Adequacy of mineralocorticoid replacement is assessed through clinical monitoring of blood pressure (supine and standing), electrolyte levels (sodium, potassium), and plasma renin activity or renin concentration. Elevated renin suggests under-replacement, while suppressed renin may indicate over-replacement. Patients should be advised about the importance of adequate salt intake, particularly during hot weather or vigorous physical activity when sodium losses through sweat are increased. Fludrocortisone dose may need temporary adjustment during summer months or in tropical climates.

Special Populations and Considerations

Pregnant women with adrenal insufficiency require careful management throughout gestation. Cortisol-binding globulin increases during pregnancy, leading to higher total cortisol levels, and the placenta produces corticotropin-releasing hormone, further complicating interpretation of hormonal tests. Higher diagnostic cortisol cutoffs should be considered: approximately 25 mcg/dL in the first trimester, 29 mcg/dL in the second, and 32 mcg/dL in the third trimester. Hydrocortisone replacement doses may need to increase, particularly in the third trimester. During labor and delivery, stress dose hydrocortisone should be administered.

In the pediatric population, hydrocortisone dosing is typically calculated based on body surface area, with physiologic replacement doses of 6 to 8 mg per square meter per day divided into two to three doses. Careful monitoring is essential because even modest glucocorticoid excess can impair linear growth. For sick day episodes in children, a total daily hydrocortisone dose of approximately 30 mg per square meter per day given as four equally divided doses is recommended, regardless of the child’s usual maintenance dose.

Elderly patients may have reduced cortisol clearance and may require lower replacement doses. Additionally, the risk of glucocorticoid-related side effects such as osteoporosis, glucose intolerance, and cardiovascular disease is heightened in older adults, making careful dose titration particularly important.

Monitoring and Long-Term Management

Long-term management of adrenal insufficiency requires regular clinical follow-up, typically every 3 to 6 months for stable patients and more frequently during dose adjustments or intercurrent illness. Assessment should include evaluation of symptoms (fatigue, appetite, weight changes), physical examination (blood pressure, body habitus, skin pigmentation in primary adrenal insufficiency), and periodic laboratory testing (electrolytes, glucose, and in primary adrenal insufficiency, renin levels).

Bone mineral density assessment should be considered at baseline and periodically, particularly in patients on higher glucocorticoid doses, as even replacement-dose glucocorticoids have been associated with reduced bone density in some studies. DHEA replacement (25 to 50 mg per day) may be considered in women with primary adrenal insufficiency who experience impaired well-being despite optimized glucocorticoid and mineralocorticoid replacement, although evidence for its benefit remains mixed.

Patient education is perhaps the most critical component of long-term management. Patients must understand the importance of medication adherence, recognize the symptoms of both under-replacement and over-replacement, know how and when to implement sick day rules, carry emergency medication and identification at all times, and communicate their condition to all healthcare providers. Family members and close contacts should also be educated about emergency hydrocortisone injection administration.

Key Point: Mortality Remains Elevated

Despite improvements in diagnosis and treatment, patients with adrenal insufficiency continue to have increased mortality rates, primarily from cardiovascular disease and infections. This underscores the importance of avoiding both over- and under-replacement of glucocorticoids and ensuring patients are well-prepared to manage intercurrent illness.

Limitations of Clinical Calculators and Tools

While calculators for cortisol interpretation, glucocorticoid conversion, and stress dosing provide valuable clinical decision support, they have important limitations that must be understood. Cortisol assay results vary significantly between different laboratory platforms, and the thresholds used in any calculator represent general guidelines rather than universal cutoffs. The immunoassay-specific variation in cortisol measurements can lead to both false-positive and false-negative diagnoses if generic thresholds are applied without consideration of the specific assay used.

Glucocorticoid equivalency tables provide approximations based on anti-inflammatory potency but do not capture the full pharmacologic profile of each steroid. Differences in duration of action, plasma half-life, tissue distribution, and mineralocorticoid activity mean that simple dose conversion may not achieve equivalent clinical effects, particularly when switching between steroids with very different pharmacokinetic profiles. Clinical monitoring after any steroid conversion is essential.

Stress dosing recommendations are largely derived from expert consensus, physiologic studies, and limited clinical data rather than large randomized controlled trials. Some recent evidence suggests that conventional stress dosing guidelines may result in over-treatment in some scenarios, while the optimal duration of increased dosing remains poorly defined. Individual patient factors, including the severity of illness, concurrent medications, and comorbidities, must always be considered alongside calculator-generated recommendations.

Global Application and Population Considerations

Adrenal insufficiency occurs in all populations worldwide, though the relative prevalence of different etiologies varies by region. Autoimmune adrenalitis predominates in developed countries, while infectious causes, particularly tuberculosis, remain important in developing regions. The diagnostic algorithms and treatment principles outlined in this guide are broadly applicable across populations, though access to specific diagnostic tests and medications may vary.

International medical organizations including the Endocrine Society, the European Society of Endocrinology, and the Society for Endocrinology have published comprehensive guidelines for the diagnosis and management of adrenal insufficiency. While these guidelines are largely concordant, some differences exist in recommended diagnostic thresholds, replacement doses, and stress dosing protocols. Healthcare providers should be familiar with the guidelines most relevant to their practice setting and patient population.

Laboratory units for cortisol measurement differ across regions. In the United States and many Asian countries, cortisol is typically reported in mcg/dL (or equivalently, micrograms per deciliter), while many European and other international laboratories report in nmol/L. The conversion factor is: nmol/L = mcg/dL multiplied by 27.6. Similarly, ACTH may be reported in pg/mL or pmol/L (conversion: pmol/L = pg/mL multiplied by 0.2202). Familiarity with both unit systems is important for interpreting published literature and applying clinical guidelines.

Validation Across Diverse Populations

The diagnostic thresholds and treatment recommendations for adrenal insufficiency have been developed and validated primarily in European and North American populations. Limited data suggest that cortisol dynamics may differ somewhat across ethnic groups, though the clinical significance of these differences remains unclear. The ACTH stimulation test has been studied in diverse populations and generally performs well as a diagnostic tool across ethnic backgrounds.

Glucocorticoid metabolism can be influenced by genetic polymorphisms in enzymes such as 11-beta-hydroxysteroid dehydrogenase and cytochrome P450 enzymes, which may affect individual dose requirements. Some populations show higher or lower activity of these enzymes, potentially necessitating dose adjustments. Additionally, body composition differences across populations may influence the relationship between weight-based or BSA-based dosing and actual glucocorticoid requirements.

Regional Variations and Alternative Calculators

Several specialized calculators and clinical tools exist for specific aspects of adrenal insufficiency management. The MDCalc Steroid Conversion Calculator focuses specifically on dose equivalency between corticosteroids and is widely used in clinical practice. The ClinCalc Corticosteroid Conversion Calculator provides similar functionality with additional educational content. For pediatric patients, the British Society for Paediatric Endocrinology and Diabetes (BSPED) has published consensus guidelines with specific dosing recommendations based on body surface area.

The Society for Endocrinology in the United Kingdom has developed specific guidance documents and emergency cards for adrenal crisis management, which are increasingly adopted internationally. The Endocrine Society (North America), European Society of Endocrinology, and Australian Endocrine Society have all published clinical practice guidelines with somewhat different but largely compatible recommendations for adrenal insufficiency management.

Frequently Asked Questions

What is adrenal insufficiency and why is it dangerous?

Adrenal insufficiency is a condition where the adrenal glands do not produce enough cortisol, a hormone essential for maintaining blood pressure, blood sugar, immune function, and the body’s response to stress. It is dangerous because without adequate cortisol, even relatively minor illnesses or injuries can trigger an adrenal crisis, which is a life-threatening emergency characterized by severe hypotension, dehydration, and shock. Without prompt treatment with glucocorticoids and intravenous fluids, adrenal crisis can be fatal. This is why patients with adrenal insufficiency must take daily replacement medication and increase their doses during illness.

What is the difference between primary and secondary adrenal insufficiency?

Primary adrenal insufficiency (Addison disease) results from destruction of the adrenal glands themselves, leading to deficiency of cortisol, aldosterone, and adrenal androgens. It is most commonly caused by autoimmune destruction. Secondary adrenal insufficiency results from insufficient ACTH production by the pituitary gland, causing cortisol and androgen deficiency but usually not aldosterone deficiency. The most common cause is chronic exogenous glucocorticoid use suppressing the HPA axis. A key clinical difference is that primary adrenal insufficiency requires both glucocorticoid and mineralocorticoid replacement, while secondary usually requires only glucocorticoids.

How is morning cortisol used to diagnose adrenal insufficiency?

Morning cortisol, measured between 8:00 and 9:00 AM when cortisol levels are naturally at their peak, is the initial screening test for adrenal insufficiency. A morning cortisol below 3 mcg/dL (83 nmol/L) is highly suggestive of adrenal insufficiency and may be sufficient for diagnosis in the appropriate clinical context. A level above 15 mcg/dL (414 nmol/L) with most modern assays effectively excludes the diagnosis. Values between 3 and 15 mcg/dL are indeterminate and require confirmatory dynamic testing, typically the ACTH stimulation test. These thresholds are assay-dependent, so clinicians should use the cutoffs appropriate for their laboratory’s specific cortisol assay.

What is the ACTH stimulation test and how is it interpreted?

The ACTH stimulation test (cosyntropin stimulation test) is the gold standard for diagnosing adrenal insufficiency. A 250 mcg dose of synthetic ACTH is administered intravenously, and serum cortisol is measured at baseline and at 30 and 60 minutes. A peak cortisol response of 18 mcg/dL (500 nmol/L) or higher at either time point traditionally excludes adrenal insufficiency, though newer assays may require a lower cutoff of 14 to 15 mcg/dL. The test directly measures the adrenal glands’ ability to produce cortisol in response to maximal stimulation. An inadequate cortisol response confirms adrenal insufficiency, and ACTH levels help distinguish primary from secondary causes.

How does the glucocorticoid dose conversion work?

Glucocorticoid dose conversion uses established potency ratios to calculate equivalent doses between different steroid medications. The reference standard is hydrocortisone 20 mg, which is equivalent to cortisone acetate 25 mg, prednisolone or prednisone 5 mg, methylprednisolone 4 mg, triamcinolone 4 mg, dexamethasone 0.75 mg, and betamethasone 0.6 mg. These equivalencies are based on anti-inflammatory (glucocorticoid) potency. The conversion multiplies the current dose by the ratio of potency factors. However, differences in half-life, duration of action, and mineralocorticoid activity mean clinical monitoring is always necessary after switching medications.

What is the recommended daily hydrocortisone replacement dose?

The Endocrine Society recommends hydrocortisone 15 to 25 mg per day for adults with adrenal insufficiency, divided into two or three doses with the largest dose taken upon waking. A common starting regimen is 10 mg in the morning, 5 mg at midday, and 5 mg in the late afternoon. The dose should be individualized based on clinical assessment, aiming for the lowest effective dose that relieves symptoms without causing signs of glucocorticoid excess. Some patients may do well on as little as 10 to 15 mg per day, while others require the full 25 mg. Body surface area-based dosing suggests approximately 8 to 10 mg per square meter per day.

What are sick day rules for adrenal insufficiency?

Sick day rules are guidelines for increasing glucocorticoid doses during illness to prevent adrenal crisis. For mild illness (temperature below 38 degrees Celsius with mild symptoms), double the daily oral hydrocortisone dose. For moderate illness (temperature above 38 degrees Celsius or significant symptoms), double or triple the daily dose. For severe illness or inability to take oral medication, administer intramuscular hydrocortisone 100 mg and seek emergency medical care. Increased dosing should continue for the duration of the illness and be gradually tapered as symptoms resolve. Patients should contact their healthcare provider if they need doubled doses for more than 3 days or if symptoms are not improving.

When should I use an emergency hydrocortisone injection?

An emergency hydrocortisone injection (typically 100 mg intramuscular for adults) should be used when a patient with adrenal insufficiency is unable to take oral medication due to persistent vomiting or altered consciousness, when there are signs of adrenal crisis (severe weakness, confusion, significant hypotension, collapse), when oral dose doubling has not improved symptoms, or after severe trauma or injury. The injection should be administered into the outer thigh muscle and emergency medical services should be called immediately. Patients and their caregivers should be trained in injection technique and should always carry their emergency kit.

How is stress dosing different for surgery?

Surgical stress dosing follows a graduated approach based on the severity of the procedure. For minor procedures under local anesthesia, taking the usual morning dose is generally sufficient with monitoring. For moderate surgery (such as joint replacement or abdominal procedures), the recommendation is 50 mg hydrocortisone intravenously at induction, followed by 25 mg every 8 hours for 24 to 48 hours. For major surgery (such as cardiac surgery or major abdominal surgery), 100 mg hydrocortisone intravenously at induction followed by 50 mg every 6 to 8 hours (200 mg per 24 hours) continuing until stable and able to eat, then taper to maintenance. The surgical team should be informed of the patient’s adrenal insufficiency before any procedure.

What is the conversion factor between mcg/dL and nmol/L for cortisol?

To convert serum cortisol from mcg/dL to nmol/L, multiply by 27.6. For example, 18 mcg/dL equals approximately 497 nmol/L (often rounded to 500 nmol/L in clinical guidelines). Conversely, to convert from nmol/L to mcg/dL, divide by 27.6. This conversion is important because different regions use different units: the United States typically uses mcg/dL, while many European, Australian, and other international laboratories report cortisol in nmol/L. Always check which unit system your laboratory uses when interpreting results and applying diagnostic thresholds.

Why is dexamethasone not recommended for adrenal insufficiency replacement?

Dexamethasone is not recommended as a routine replacement therapy for adrenal insufficiency for several reasons. Its very high potency (approximately 26.67 times more potent than hydrocortisone per milligram) makes precise dose titration extremely difficult at the small doses needed for physiologic replacement. Its long duration of action (36 to 72 hours) means it cannot replicate the normal cortisol circadian rhythm. It has no mineralocorticoid activity, so additional fludrocortisone would always be needed in primary adrenal insufficiency. Studies show higher rates of Cushingoid side effects with dexamethasone replacement compared to hydrocortisone. However, it remains important in certain clinical contexts such as acute stress dosing or when other preparations are unavailable.

What role does DHEA play in adrenal insufficiency?

Dehydroepiandrosterone (DHEA) is an adrenal androgen that is deficient in both primary and secondary adrenal insufficiency. DHEA and its sulfated form DHEAS serve as precursors for sex hormones and may play roles in well-being, mood, libido, and immune function. Some guidelines suggest considering DHEA supplementation (25 to 50 mg daily) in women with primary adrenal insufficiency who report impaired well-being despite optimized glucocorticoid and mineralocorticoid replacement. Morning DHEAS levels can be monitored to guide dosing. However, evidence for the clinical benefit of DHEA replacement remains mixed, and it is not universally recommended. A DHEAS level above 65 mcg/dL can also be used as a screening tool to help exclude adrenal insufficiency.

How does body surface area affect hydrocortisone dosing?

Body surface area is considered more accurate than body weight alone for estimating physiologic cortisol requirements because cortisol production correlates with metabolic rate, which is better predicted by body surface area. The Du Bois formula estimates BSA using height and weight. Physiologic cortisol production is approximately 5 to 10 mg per square meter per day, and accounting for oral bioavailability, the recommended replacement dose is about 8 to 10 mg of hydrocortisone per square meter per day. A person with a BSA of 1.7 square meters would therefore require approximately 13.6 to 17 mg per day. This provides a more individualized starting point than a fixed dose range, though clinical response remains the primary guide for dose adjustment.

What are the signs of glucocorticoid over-replacement?

Signs of glucocorticoid over-replacement mirror those of Cushing syndrome and include weight gain (particularly central obesity), moon facies (rounded facial appearance), dorsocervical fat pad (buffalo hump), purple striae on the abdomen and thighs, easy bruising, thin fragile skin, proximal muscle weakness, hypertension, hyperglycemia or frank diabetes, osteoporosis, increased susceptibility to infections, mood changes (anxiety, insomnia, euphoria), and reduced wound healing. Even modest overtreatment sustained over years can contribute to cardiovascular disease, metabolic syndrome, and reduced bone density. This is why guidelines emphasize using the lowest effective replacement dose and regularly reassessing dosing adequacy.

What are the signs of glucocorticoid under-replacement?

Signs of glucocorticoid under-replacement include persistent fatigue and weakness, loss of appetite and nausea, unexplained weight loss, orthostatic hypotension (dizziness upon standing), hypoglycemia, abdominal pain, joint and muscle aches, increased salt craving (in primary adrenal insufficiency), and a general sense of malaise. Severe under-replacement can lead to adrenal crisis, especially during physiologic stress. In primary adrenal insufficiency, progressive hyperpigmentation of the skin and mucous membranes may indicate chronically elevated ACTH from inadequate cortisol replacement. Any of these symptoms should prompt reassessment of the glucocorticoid dose and consideration of potential contributing factors such as intercurrent illness.

Can adrenal insufficiency be caused by medications?

Yes, the most common cause of adrenal insufficiency worldwide is iatrogenic, resulting from chronic exogenous glucocorticoid use that suppresses the HPA axis. This can occur with oral, inhaled, topical, injected, or even nasal glucocorticoids if used at sufficient doses for sufficient duration, typically more than 2 to 3 weeks of supraphysiologic dosing. Other medications that can cause adrenal insufficiency include ketoconazole, etomidate, mitotane, metyrapone, and immune checkpoint inhibitors used in cancer immunotherapy. Opioids can also suppress ACTH secretion and lead to secondary adrenal insufficiency. Abrupt withdrawal of long-term glucocorticoid therapy without gradual tapering is a common and preventable cause of adrenal crisis.

How do I convert cortisol units between mcg/dL and nmol/L?

The conversion between cortisol units uses the molecular weight of cortisol (362.46 g/mol). To convert from mcg/dL to nmol/L, multiply by 27.6. To convert from nmol/L to mcg/dL, divide by 27.6. Common reference values in both units: a morning cortisol of 3 mcg/dL equals approximately 83 nmol/L, 10 mcg/dL equals 276 nmol/L, 14 mcg/dL equals 386 nmol/L, 15 mcg/dL equals 414 nmol/L, and 18 mcg/dL equals approximately 497 nmol/L (often rounded to 500 nmol/L). This calculator provides automatic unit conversion to help users working with either measurement system.

What is the role of ACTH measurement in adrenal insufficiency diagnosis?

ACTH measurement is crucial for distinguishing the type of adrenal insufficiency. In primary adrenal insufficiency, the pituitary gland responds to low cortisol by producing excess ACTH, resulting in elevated levels typically above 100 pg/mL (22 pmol/L) and often several times the upper limit of normal. In secondary or tertiary adrenal insufficiency, ACTH levels are low or inappropriately normal despite low cortisol, because the problem lies in the pituitary or hypothalamus. ACTH should ideally be measured simultaneously with an early morning cortisol level. The combination of low cortisol with high ACTH strongly suggests primary adrenal insufficiency, while low cortisol with low or normal ACTH indicates a central cause.

How should glucocorticoid doses be adjusted during pregnancy?

During pregnancy, cortisol-binding globulin increases progressively, leading to higher total cortisol levels that can complicate interpretation of laboratory tests. Hydrocortisone remains the preferred glucocorticoid because it is inactivated by placental 11-beta-hydroxysteroid dehydrogenase type 2 and does not cross the placenta in significant amounts. The dose may need to increase by 20 to 40 percent, particularly in the third trimester, guided by clinical assessment. Diagnostic cortisol cutoffs should be higher during pregnancy: approximately 25, 29, and 32 mcg/dL for the first, second, and third trimesters respectively. Stress dosing during labor (100 mg hydrocortisone IV followed by 200 mg per 24 hours) is essential. After delivery, doses should be tapered to pre-pregnancy levels over 48 hours.

What is the difference between hydrocortisone and cortisone acetate?

Hydrocortisone is bioidentical cortisol, the body’s natural glucocorticoid, and is active immediately upon absorption. Cortisone acetate is a prodrug that must be converted to cortisol by the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 in the liver. Due to this conversion step and slightly lower bioavailability, cortisone acetate requires a higher dose (25 mg cortisone acetate is approximately equivalent to 20 mg hydrocortisone). Both medications provide some mineralocorticoid activity. The conversion ratio is typically considered 1.25:1, meaning 25 mg cortisone acetate provides glucocorticoid coverage roughly equivalent to 20 mg hydrocortisone. Hydrocortisone is generally preferred for replacement therapy due to more predictable pharmacokinetics.

How long should increased stress doses be maintained during illness?

Increased glucocorticoid doses should be maintained for the duration of the physiologic stress, not for a fixed number of days. For most mild to moderate illnesses, this typically means 2 to 3 days or until symptoms resolve. However, stress dosing is not limited to 3 days and should continue as long as the precipitating condition persists, such as ongoing fever, infection, or recovery from surgery. Once the illness or stress has resolved, the dose can be tapered back to the maintenance level, either abruptly for short courses (3 days or less) or gradually for longer periods of increased dosing. Patients should contact their healthcare provider if they need increased doses for more than 3 days or if symptoms are worsening despite dose escalation.

Is emotional or psychological stress a reason to increase glucocorticoid doses?

The role of psychological stress in precipitating adrenal crisis is debated, and current evidence suggests that most routine emotional stress does not require dose adjustment. However, acute and severe psychological stress, such as bereavement, severe traumatic experiences, or acute mental health crises, may warrant a short-term increase. Some guidelines suggest taking an additional 5 to 10 mg of hydrocortisone before anticipated stressful events such as important examinations. The NICE guidelines suggest considering 1 to 2 days of sick-day dosing during severe mental health crises. Clinical judgment should guide these decisions, and long-term dose increases for chronic psychological stress are generally not recommended due to the risk of glucocorticoid excess.

What is the mineralocorticoid activity of different glucocorticoids?

Glucocorticoids vary in their mineralocorticoid activity, which is important when selecting replacement therapy for primary adrenal insufficiency. Hydrocortisone has moderate mineralocorticoid activity (approximately 1 relative to itself). Cortisone acetate has similar mineralocorticoid potency to hydrocortisone. Prednisolone and prednisone have about 60 percent of the mineralocorticoid activity of hydrocortisone per equivalent glucocorticoid dose. Methylprednisolone has approximately 50 percent. Dexamethasone and betamethasone have negligible mineralocorticoid activity. When converting from hydrocortisone to a synthetic glucocorticoid with less mineralocorticoid activity, patients with primary adrenal insufficiency may need to increase their fludrocortisone dose to compensate for the lost mineralocorticoid effect.

How accurate are online glucocorticoid conversion calculators?

Online glucocorticoid conversion calculators provide a useful starting point for dose conversion but have inherent limitations. The equivalency ratios they use are approximations based on anti-inflammatory potency and may not precisely predict clinical equivalence for all effects. Different steroids have different durations of action, pharmacokinetic profiles, tissue distributions, and mineralocorticoid activities that simple dose conversion cannot capture. Individual patient factors such as liver function, concurrent medications, and genetic polymorphisms in steroid-metabolizing enzymes can affect the actual clinical response. Conversion calculators should be used as guides, with clinical monitoring to assess the adequacy of the new dose. When in doubt, consult an endocrinologist for complex steroid conversions.

What laboratory tests should be done to confirm adrenal insufficiency?

The recommended laboratory evaluation includes an early morning serum cortisol (drawn between 8:00 and 9:00 AM), a simultaneous plasma ACTH level, the ACTH stimulation test (250 mcg cosyntropin with cortisol at 0, 30, and 60 minutes), serum electrolytes (looking for hyponatremia and hyperkalemia), a basic metabolic panel including glucose, plasma renin activity or concentration, and serum aldosterone. Additional tests may include DHEAS, 21-hydroxylase antibodies (to identify autoimmune etiology in primary adrenal insufficiency), and adrenal imaging (CT or MRI) when appropriate. In suspected secondary adrenal insufficiency, pituitary function testing and MRI of the pituitary gland should be considered.

What is an adrenal crisis and how is it treated?

An adrenal crisis is a life-threatening emergency caused by acute cortisol deficiency. Symptoms include severe hypotension or circulatory shock, extreme weakness and fatigue, severe abdominal pain, nausea and vomiting, altered consciousness or confusion, fever, and biochemical derangements including hyponatremia, hyperkalemia (in primary adrenal insufficiency), and hypoglycemia. Emergency treatment involves immediate intravenous or intramuscular hydrocortisone 100 mg bolus, followed by 200 mg hydrocortisone over 24 hours, aggressive intravenous fluid resuscitation with normal saline (1 to 2 liters in the first hour), correction of hypoglycemia if present, and monitoring in an intensive care setting. Treatment should not be delayed for diagnostic testing.

How does the calculator estimate physiologic replacement dose?

The replacement dose module uses body surface area and weight to estimate the physiologic hydrocortisone requirement. Body surface area is calculated using the Du Bois formula, and the estimated daily cortisol production rate of approximately 5 to 10 mg per square meter per day is used as the basis. Accounting for oral bioavailability (approximately 90 to 100 percent for hydrocortisone), the calculator suggests a replacement dose range of 8 to 10 mg per square meter per day. It also provides weight-based estimates using 0.12 to 0.15 mg per kilogram per day as an alternative approach. These are starting estimates only; the actual dose should be individualized based on clinical response, recognizing that individual cortisol production rates vary approximately 5-fold across the population.

How often should I see my endocrinologist for adrenal insufficiency?

Patients with stable adrenal insufficiency on established replacement therapy should typically be reviewed by their endocrinologist every 3 to 6 months. More frequent visits may be needed when first diagnosed, during dose adjustments, after adrenal crisis episodes, during pregnancy, or when intercurrent illnesses are frequent. Annual assessments should include clinical evaluation of replacement adequacy, blood pressure monitoring, electrolyte and metabolic panel, body weight and composition assessment, and screening for osteoporosis risk. In primary adrenal insufficiency, screening for associated autoimmune conditions (thyroid disease, type 1 diabetes, celiac disease) should be performed periodically, as these conditions share an autoimmune basis and can develop over time.

How does this calculator handle pediatric dosing?

The calculator includes body surface area estimation using the Du Bois formula, which can be applied to both adults and older children. For pediatric replacement dosing, the recommended range is 6 to 8 mg of hydrocortisone per square meter per day, which is lower than the adult recommendation of 8 to 10 mg per square meter per day. For pediatric sick day dosing, the recommended target is approximately 30 mg per square meter per day divided into four equal doses. However, pediatric dosing is complex and varies with age, pubertal status, and the specific cause of adrenal insufficiency (particularly in congenital adrenal hyperplasia, where higher doses may be needed). All pediatric dosing decisions should be made in consultation with a pediatric endocrinologist.

What is the prognosis for patients with adrenal insufficiency?

With appropriate replacement therapy and patient education, most patients with adrenal insufficiency can lead active, productive lives. However, studies consistently show that patients with adrenal insufficiency have increased mortality rates compared to the general population, primarily from cardiovascular disease and infections, with standardized mortality ratios of approximately 1.5 to 2.0. Quality of life is often impaired, with persistent fatigue being the most common complaint even with optimized therapy. The risk of adrenal crisis remains significant at approximately 6 to 8 episodes per 100 patient-years. Outcomes are best for patients who understand their condition, adhere to their medication regimen, implement sick day rules appropriately, and maintain regular follow-up with their endocrinologist.

Conclusion

Adrenal insufficiency is a complex endocrine condition that requires lifelong management with careful attention to glucocorticoid replacement dosing, recognition of situations requiring dose adjustment, and preparedness for adrenal crisis. The Adrenal Insufficiency Calculator provides tools for interpreting cortisol laboratory values in the context of established diagnostic algorithms, converting between different glucocorticoid medications using validated potency ratios, estimating physiologic replacement doses based on body surface area and weight, and calculating appropriate stress doses for various clinical scenarios.

However, no calculator can replace clinical judgment. The interpretation of cortisol levels must account for assay-specific variations, patient-specific factors, and the broader clinical picture. Glucocorticoid conversions provide starting estimates that require clinical validation. Stress dosing guidelines represent consensus recommendations that may need modification based on individual patient circumstances. All patients with adrenal insufficiency should maintain an ongoing relationship with an endocrinologist and be empowered with the knowledge to manage their condition safely in partnership with their healthcare team.